findmyKOL
Clinical trialNCT03938246CompletedPhase 2Interventional

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

SponsorSagimet Biosciences Inc.Enrollment142MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Beijing Youan Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Foshan First People'S Hospital

    Foshan, Guangdong, China

  • Nanfang Hospital

    Guangzhou, Guangdong, China

  • the First Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • the Third Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • the Second Hospital of Nanjing

    Nanjing, Jiangsu, China

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Shanghai Ninth People'S Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China

  • the Affiliated Hospital of Hangzhou Normal University

    Hangzhou, Zhejiang, China

United States
  • Prosciento

    Chula Vista, California, United States

  • Catalina Research Institute

    Montclair, California, United States

  • Clinical Trials Research

    Sacramento, California, United States

  • University of California San Diego (ucsd)

    San Diego, California, United States

  • Panax

    Miami Lakes, Florida, United States

  • Lucas Research

    Morehead City, North Carolina, United States

  • Texas Diabetes and Endocrinology - Austin

    Austin, Texas, United States

  • Texas Digestive Disease Consultants - Cedar Park

    Cedar Park, Texas, United States

  • Texas Digestive Disease Consultants - Dallas

    Dallas, Texas, United States

  • Texas Digestive Disease Consultant - Ft Worth

    Fort Worth, Texas, United States

  • Pinnacle Clinical Research - San Antonio

    San Antonio, Texas, United States

  • Texas Digestive Disease Consultants - Webster

    Webster, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Mar 2019
Primary completion
2 Oct 2021
Completion
2 Oct 2021
Last update posted
19 Dec 2024
Registered enrollment
142
Registry id
NCT03938246

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.